おすすめの製品
グレード
pharmaceutical primary standard
APIファミリー
tribenoside
メーカー/製品名
EDQM
アプリケーション
pharmaceutical (small molecule)
フォーマット
neat
輸送温度
wet ice
保管温度
−20°C
InChI
1S/C29H34O6/c1-2-32-29-26(30)28(34-20-24-16-10-5-11-17-24)27(35-29)25(33-19-23-14-8-4-9-15-23)21-31-18-22-12-6-3-7-13-22/h3-17,25-30H,2,18-21H2,1H3/t25?,26-,27-,28-,29?/m1/s1
InChI Key
ULLNJSBQMBKOJH-NUZMXOBKSA-N
関連するカテゴリー
詳細
This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.
アプリケーション
Tribenoside EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.
包装
The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.
その他情報
Sales restrictions may apply.
保管分類コード
11 - Combustible Solids
引火点(°F)
Not applicable
引火点(℃)
Not applicable
最新バージョンのいずれかを選択してください:
Glyvenol therapy in varicose veins an evaluation of its effectiveness.
East African medical journal, 58(7), 532-538 (1981-07-01)
The Journal of rheumatology, 10(2), 267-281 (1983-04-01)
Experiments in adult hens with chemically induced osteoarthrosis or osteoarthritis (OA) of the knee joint have shown that daily treatment with tribenoside (Glyvenol) in single oral doses of 50 mg/kg or 150 mg/kg markedly reduced the intensity and frequency of
Reproductive toxicology (Elmsford, N.Y.), 31(4), 464-469 (2010-12-25)
Tribenoside is used for the treatment of haemorrhoids and varicose veins, frequently in pregnant women as well, but published data regarding its possible teratogenic effect are not available. Thus the risk of congenital abnormalities (CAs) was estimated in cases of
[Test of potential antiarthritic drugs on spontaneous arthritis of mice].
Zeitschrift fur Rheumatologie, 42(4), 203-205 (1983-07-01)
Farmakologiia i toksikologiia, 44(1), 74-77 (1981-01-01)
A study was made on the mechanism of action of the antivaricose agent tribenol (ethyl-3,5,6-tri-O-benzyl-D-glucofuranozide; glivenol) on the activity of hydroxyreductase on the Krebs cycle and glycolysis during occlusion of the femoral vein and its inflammation in rats. It was
ライフサイエンス、有機合成、材料科学、クロマトグラフィー、分析など、あらゆる分野の研究に経験のあるメンバーがおります。.
製品に関するお問い合わせはこちら(テクニカルサービス)